Method for constructing ribosome inactivating protein gene virus vector and expressing active proteins in tumor cell through ribosome inactivated protein gene virus vector

A technology for ribosome inactivation and tumor cells, which is applied in the construction of ribosome inactivation protein gene viral vectors and the expression of active proteins in tumor cells. problems, to achieve significant toxicological effects, significant cytotoxic effects, and significant effects

Pending Publication Date: 2020-02-04
成都富岱生物医药有限公司
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, whether the ribosome inactivating protein is expressed in Escherichia coli using a prokaryotic vector or expressed in a plant virus vector system, it cannot be expressed in mammalian cells and cannot be used for anti-tumor gene therapy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for constructing ribosome inactivating protein gene virus vector and expressing active proteins in tumor cell through ribosome inactivated protein gene virus vector
  • Method for constructing ribosome inactivating protein gene virus vector and expressing active proteins in tumor cell through ribosome inactivated protein gene virus vector
  • Method for constructing ribosome inactivating protein gene virus vector and expressing active proteins in tumor cell through ribosome inactivated protein gene virus vector

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] Step 1: Codon optimization of the alpha charantin gene

[0043] 1 Experimental method

[0044]Three professional codon optimization software were used to simultaneously optimize the mammalian codon of the mature region of alpha-momorcharin, combining the advantages of each software to obtain an ideal optimization result. The optimization process follows the following main principles: ① species codon usage preference, ② GC content, ③ CpG dinucleotide content, ④ cryptic splice sites, ⑤ mature PolyA sites in advance, ⑥ stagnation points and ribosome binding sites, ⑦ Negative strand CG island, ⑧RNA instability motif (ARE), ⑨repeated sequence, ⑩restriction enzyme cutting site. In addition, Kozak sequence and SD sequence are used to improve mRNA translation efficiency, and TGA stop codon is used to improve translation termination signal.

[0045] 2 Codon optimization results

[0046] 2.1 Analysis of amino acid expression rate before optimization

[0047] See figure 2 . ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the technical field of bioengineering and specifically discloses a method for constructing a ribosome inactivating protein gene virus vector and expressing active proteins intumor cells through the ribosome inactivated protein gene virus vector. The method comprises the following steps that first, suitable ribosome inactivated proteins are selected, and codon optimizationfor humanized expression is conducted on mature region genes of the ribosome inactivated proteins; second, an adenovirus carrier of wild type and optimized genes is constructed, and recombinant viruses are packaged; and third, recombinant adenoviruses infect the tumor cells, the recombinant adenoviruses express proteins in the tumor cells through detection, and the anti-tumor effect of the recombinant adenoviruses is detected. According to the method, an alpha-charantin gene is subjected to codon optimization, an expression vector system for the adenoviruses capable of infecting the tumor cells of mammals is constructed so as to be suitable for expressing the active proteins in the tumor cells, and the defects that in the prior art, a prokaryotic cell expression system can only be expressed in escherichia coli when being used, and a plant virus vector can only be expressed in plant cells but cannot be expressed in the tumor cells and kill tumors when being used are overcome.

Description

Technical field: [0001] The application of the present invention belongs to the technical field of bioengineering, and more specifically relates to a method for constructing a ribosome inactivating protein gene viral vector and expressing the active protein in tumor cells. Background technique: [0002] Ribosome Inactivating Proteins (RIPs) are a class of toxic proteins mainly distributed in plants, which have RNA N-glycosidase activity. RIPs have highly conserved active cleft residues and secondary structures in the active site region, which can act on the large subunit 28S of eukaryotic cells to inactivate ribosomes, inhibit protein biosynthesis, and produce cytotoxic effects on cells. RIPs are divided into three types. Type I RIP is a single peptide chain protein with a molecular weight of about 11-30 kDa, such as bitter melon ribosome inactivating protein, trichosanthin (TCS), pokeweed protein (PAP), loofah toxin ( 1uffin), saporin, etc. Most ribosome inactivating prote...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/861C12N9/24A61K48/00A61K38/47A61P35/00
CPCC12N15/86C12N9/2497C12Y302/02022A61K48/005A61K38/47A61P35/00C12N2800/22C12N2710/10343
Inventor 刘梦铃
Owner 成都富岱生物医药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products